(5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione

C88H83N15O12 — CID 158146279

IUPAC(5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione
SMILESCOc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4cc(C)c5c(cnn5C(C)C)c4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4cc(C)c5nn(C(C)C)cc5c4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4cc(C)c5nn(C)cc5c4)cc3)NC(=O)NC1=O)C2
InChIInChI=1S/2C30H29N5O4.C28H25N5O4/c1-17(2)35-26-18(3)11-21(12-22(26)14-31-35)19-5-8-23(9-6-19)30(28(37)32-29(38)33-30)16-34-15-20-7-10-24(39-4)13-25(20)27(34)36;1-17(2)35-15-22-12-21(11-18(3)26(22)33-35)19-5-8-23(9-6-19)30(28(37)31-29(38)32-30)16-34-14-20-7-10-24(39-4)13-25(20)27(34)36;1-16-10-19(11-20-13-32(2)31-24(16)20)17-4-7-21(8-5-17)28(26(35)29-27(36)30-28)15-33-14-18-6-9-22(37-3)12-23(18)25(33)34/h5-14,17H,15-16H2,1-4H3,(H2,32,33,37,38);5-13,15,17H,14,16H2,1-4H3,(H2,31,32,37,38);4-13H,14-15H2,1-3H3,(H2,29,30,35,36)/t2*30-;28-/m000/s1
InChIKeyFUOCACGTBRUGQT-PAQMGMDOSA-N
MW1542.72 g/mol
LogP11.83
Rot. Bonds17

About (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione

(5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione (PubChem CID 158146279) has the molecular formula C88H83N15O12 and a molecular weight of 1542.72 g/mol. Its IUPAC name is (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione.

Molecular Properties

Compound Name(5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione
PubChem CID158146279
Molecular FormulaC88H83N15O12
Molecular Weight1542.72 g/mol
Exact Mass1541.63
IUPAC Name(5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione
SMILESCOc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4cc(C)c5c(cnn5C(C)C)c4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4cc(C)c5nn(C(C)C)cc5c4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4cc(C)c5nn(C)cc5c4)cc3)NC(=O)NC1=O)C2
InChIInChI=1S/2C30H29N5O4.C28H25N5O4/c1-17(2)35-26-18(3)11-21(12-22(26)14-31-35)19-5-8-23(9-6-19)30(28(37)32-29(38)33-30)16-34-15-20-7-10-24(39-4)13-25(20)27(34)36;1-17(2)35-15-22-12-21(11-18(3)26(22)33-35)19-5-8-23(9-6-19)30(28(37)31-29(38)32-30)16-34-14-20-7-10-24(39-4)13-25(20)27(34)36;1-16-10-19(11-20-13-32(2)31-24(16)20)17-4-7-21(8-5-17)28(26(35)29-27(36)30-28)15-33-14-18-6-9-22(37-3)12-23(18)25(33)34/h5-14,17H,15-16H2,1-4H3,(H2,32,33,37,38);5-13,15,17H,14,16H2,1-4H3,(H2,31,32,37,38);4-13H,14-15H2,1-3H3,(H2,29,30,35,36)/t2*30-;28-/m000/s1
InChIKeyFUOCACGTBRUGQT-PAQMGMDOSA-N
XLogP11.83
TPSA316.68 Ų
H-Bond Donors6
H-Bond Acceptors18
Rotatable Bonds17
Heavy Atoms115
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001542.72
LogP ≤ 511.83
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione?
The IUPAC name of (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione (CID 158146279) is (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione.
What is the SMILES notation for (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione?
The canonical SMILES for (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione is COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4cc(C)c5c(cnn5C(C)C)c4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4cc(C)c5nn(C(C)C)cc5c4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4cc(C)c5nn(C)cc5c4)cc3)NC(=O)NC1=O)C2.
What is the InChIKey of (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione?
The InChIKey is FUOCACGTBRUGQT-PAQMGMDOSA-N. The full InChI is InChI=1S/2C30H29N5O4.C28H25N5O4/c1-17(2)35-26-18(3)11-21(12-22(26)14-31-35)19-5-8-23(9-6-19)30(28(37)32-29(38)33-30)16-34-15-20-7-10-24(39-4)13-25(20)27(34)36;1-17(2)35-15-22-12-21(11-18(3)26(22)33-35)19-5-8-23(9-6-19)30(28(37)31-29(38)32-30)16-34-14-20-7-10-24(39-4)13-25(20)27(34)36;1-16-10-19(11-20-13-32(2)31-24(16)20)17-4-7-21(8-5-17)28(26(35)29-27(36)30-28)15-33-14-18-6-9-22(37-3)12-23(18)25(33)34/h5-14,17H,15-16H2,1-4H3,(H2,32,33,37,38);5-13,15,17H,14,16H2,1-4H3,(H2,31,32,37,38);4-13H,14-15H2,1-3H3,(H2,29,30,35,36)/t2*30-;28-/m000/s1.
What are the key properties of (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione?
(5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione has a molecular weight of 1542.72 g/mol, XLogP of 11.83, 17 rotatable bonds, 6 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-5-[4-(2,7-dimethylindazol-5-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-1-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-(7-methyl-2-propan-2-ylindazol-5-yl)phenyl]imidazolidine-2,4-dione is sourced from PubChem (CID 158146279), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).